HDAC6 and glioblastoma: As a result, we obtained that the silencing of HDAC6 inhibits cell growth (Figure 7), which makes us think that, by promoting proliferation, HDAC6 has an oncogenic role and therefore may be a therapeutic target in glioblastoma.